A Biosensor for the Quantitative Detection of Adalimumab in Blood Plasma
A highly accurate, precise and rapid biosensor for measuring the concentration of adalimumab in the blood in rheumetoid arthritis patients
Published: 15th June 2020

Patents
- US Provisional Patent Application filed on 29/08/2019
IP Status
- Provisional patent
Seeking
- Development partner
- Commercial partner
- Licensing
- University spin out
- Seeking investment